Indian Journal of Community Medicine

ORIGINAL ARTICLE
Year
: 2012  |  Volume : 37  |  Issue : 2  |  Page : 89--94

Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence


Savanna Reid 
 School of Community Health Sciences, University of Nevada at Las Vegas, 4505 Maryland Parkway, Las Vegas, NV, USA

Correspondence Address:
Savanna Reid
431 Sunburst Dr. Henderson, NV 89002
USA

Background: Unsafe medical injections are a prevalent risk factor for viral hepatitis and HIV in India. Objectives: This review undertakes a cost-benefit assessment of the auto-disable syringe, now being introduced to prevent the spread of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV). Materials and Methods: The World Health Organization methods for modeling the global burden of disease from unsafe medical injections are reproduced, correcting for the concentrated structure of the HIV epidemic in India. A systematic review of risk factor analyses in India that investigate injection risks is used in the uncertainty analysis. Results: The median population attributable fraction for hepatitis B carriage associated with recent injections is 46%, the median fraction of hepatitis C infections attributed to unsafe medical injections is 38%, and the median fraction of incident HIV infections attributed to medical injections is 12% in India. The modeled incidence of blood-borne viruses suggests that introducing the auto-disable syringe will impose an incremental cost of $46-48 per disability adjusted life year (DALY) averted. The epidemiological evidence suggests that the incremental cost of introducing the auto-disable syringe for all medical injections is between $39 and $79 per DALY averted. Conclusions: The auto-disable syringe is a cost-effective alternative to the reuse of syringes in a country with low prevalence of blood-borne viruses.


How to cite this article:
Reid S. Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence.Indian J Community Med 2012;37:89-94


How to cite this URL:
Reid S. Estimating the burden of disease from unsafe injections in India: A cost-benefit assessment of the auto-disable syringe in a country with low blood-borne virus prevalence. Indian J Community Med [serial online] 2012 [cited 2021 Apr 16 ];37:89-94
Available from: https://www.ijcm.org.in/article.asp?issn=0970-0218;year=2012;volume=37;issue=2;spage=89;epage=94;aulast=Reid;type=0